Asthma and Allergic Inflammation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: closed (17 November 2023) | Viewed by 3233
Special Issue Editor
Interests: asthma; lung immunology; COPD and COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Asthma and allergic diseases are public health issues worldwide and are challenges in the modern medical landscape. The condition is widespread, and often goes undiagnosed or inadequately, leading to many deaths. The impacts on clinical, economic and social affect healthcare systems in many countries and compromise the quality of life of patients. Although good treatments and a plethora of guidelines and strategies, no significant progress has been made in the past 20 years. These are multifactorial pathologies with genetic and environmental triggers and unique pathophysiological underlying dynamics. Their different cellular, molecular, and clinical characteristics make these diseases a true medical mystery that needs to be deciphered.
This Special Issue welcomes the submission of original articles, systematic reviews, communications and other types of articles on related topics. All manuscripts will follow standard journal peer-review practices, and those accepted for publication will appear in the “Asthma and Allergic Inflammation”. We look forward to receiving your contributions to the Special Issue.
Dr. Corrado Pelaia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- asthma
- allergen immunotherapy
- rhinitis
- Epidemiology
- personalized medicine
- IgE
- IL-5
- IL-4
- IL-13
- monoclonal antibodies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.